Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Express News | Bionomics Receives Notice Of Allowance For US Patent On Substituted-N-Heteroaryl Compounds For Cognitive Function And CNS Disorders
ADRs Close Lower; Bionomics Ltd. Declines 18%
Bionomics Poised for Phase 3 Success With BNC210 Following Favorable FDA Meeting: A Strong Buy Recommendation
Express News | Bionomics Announced The Favorable Outcomes Of An EoP2 Meeting With The FDA On The Development Of BNC210 In Post-traumatic Stress Disorder
Express News | Bionomics Ltd - to Initiate Phase 3 Program in Q4 2024
Express News | Bionomics Announces Successful End-of-Phase 2 Meeting With the FDA on the Development of Bnc210 in Post-Traumatic Stress Disorder
HC Wainwright & Co. Reiterates Buy on Bionomics, Maintains $8 Price Target
Buy Rating Affirmed on Bionomics as BNC210 Enters Critical Phase 3 Trial for Social Anxiety Disorder
Trending Stocks Today | Onconetix Soars 35.1% Pre-Market
Express News | Bionomics Has Initiated Patient Screening For The Phase 3 AFFIRM-1 Trial Evaluating The Safety And Efficacy Of BNC210 For The Acute, As-needed Treatment Of Social Anxiety Disorder, Topline Results Are Expected In Q3 2025
Express News | Bionomics Ltd - Affirm-1 to Enroll 330 Adult Patients With Sad
Express News | Bionomics Ltd - Topline Results Are Expected in Q3 2025
Express News | Bionomics Files For Resale Of Up To 3.64B Ordinary Shares By The Selling Shareholder
Express News | Bionomics Ltd Files for Resale of up to 3.64 Mln Ordinary Shares by the Selling Shareholder - SEC Filing
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
H.C. Wainwright Maintains Bionomics(BNOX.US) With Buy Rating, Maintains Target Price $8
Bionomics | 6-K: Report of foreign private issuer (related to financial reporting)
No Data
No Data